Atossa Therapeutics
ATOS
#9969
Rank
A$63.54 M
Marketcap
A$7.38
Share price
-2.85%
Change (1 day)
614.04%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): A-$0.38

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.36. In 2024 the company made an earnings per share (EPS) of A-$0.29 an increase over its 2023 EPS that were of A-$0.35.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.3831.28%
2024A-$0.29-16.67%
2023A-$0.3514.29%
2022A-$0.3016.67%
2021A-$0.26-90.86%
2020A-$2.84-2.96%
2019A-$2.93-63.09%
2018A-$7.94-49.63%
2017A-$15.77-57.87%
2016A-$37.43-74.01%
2015A-$144.01-9.18%
2014A-$158.56-12.86%
2013A-$181.9670.73%
2012A-$106.5734.08%
2011A-$79.49263.47%
2010A-$21.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$16.09-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.81-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.21-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A-$1.27 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A-$0.30-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA